Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing
Volume 48, Issue 2 (Feb 2010)

Issues

Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis

Jessica Zuin
  • Xeptagen SpA, Marghera, Venice, Italy
/ Gianluca Veggiani
  • Xeptagen SpA, Marghera, Venice, Italy
/ Paolo Pengo
  • Xeptagen SpA, Marghera, Venice, Italy
/ Andrea Gallotta
  • Xeptagen SpA, Marghera, Venice, Italy
/ Alessandra Biasiolo
  • Department of Clinical and Experimental Medicine, University of Padua, Padua, Italy
/ Natascia Tono
  • Istituto Oncologico Veneto – I.O.V. (IRCCS), Padua, Italy
/ Angelo Gatta
  • Department of Clinical and Experimental Medicine, University of Padua, Padua, Italy
/ Patrizia Pontisso
  • Department of Clinical and Experimental Medicine, University of Padua, Padua, Italy
/ Radovan Toth
  • Laboratory of Molecular, Biostructural and Nanomaterial Modeling, Consorzio per l'AREA di Ricerca Scientifica e Tecnologica di Trieste, AREA Science Park, Trieste, Italy
/ Dean Cerin
  • Laboratory of Molecular, Biostructural and Nanomaterial Modeling, Consorzio per l'AREA di Ricerca Scientifica e Tecnologica di Trieste, AREA Science Park, Trieste, Italy
/ Vladimir Frecer
  • Laboratory of Molecular, Biostructural and Nanomaterial Modeling, Consorzio per l'AREA di Ricerca Scientifica e Tecnologica di Trieste, AREA Science Park, Trieste, Italy
/ Sabrina Meo
  • ABO Association, Center for the Study of Biological Markers of Malignancy, AULSS12, Venice, Italy
/ Massimo Gion
  • Center for the Study of Biological Markers of Malignancy, AULSS12, Venice, Italy
/ Giorgio Fassina
  • Xeptagen SpA, Marghera, Venice, Italy
/ Luca Beneduce
  • Xeptagen SpA, Marghera, Venice, Italy
Published Online: 2009-12-10 | DOI: https://doi.org/10.1515/CCLM.2010.044

Abstract

Background: Squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) is a useful biomarker for the risk of development of hepatocellular carcinoma (HCC) in patients with cirrhosis due to its progressive increase associated to HCC evolution. In patients with cirrhosis, other assays have been affected by interfering reactivities of IgM. In this study, the analytical specificity of the SCCA-IgM assay was assessed by evaluating SCCA-IgM measurement dependence on different capture phases, and by measuring the recovery of SCCA-IgM reactivity following serum fractionation.

Methods: Serum samples from 82 patients with cirrhosis were analyzed. SCCA-IgM was measured using the reference test (Hepa-IC, Xeptagen, Italy) that is based on rabbit oligoclonal anti-squamous cell carcinoma antigen (SCCA) and a dedicated ELISA with a mouse monoclonal anti-SCCA as the capture antibody.

Results: SCCA-IgM concentrations measured with the reference assay (median value=87 AU/mL) were higher than those measured with the mouse monoclonal test (median value=78 AU/mL). However, the differences in the SCCA-IgM distribution were not statistically significant (p>0.05). When SCCA-IgM concentrations measured with both tests were compared, a linear correlation was found (r=0.77, p<0.05). Fractionation of the most reactive sera by gel-filtration chromatography showed that total recovery of SCCA-IgM reactivity was seen only in the fractions corresponding to components with a molecular weight higher than IgM and SCCA (>2000 kDa) with both tests.

Conclusions: The equivalence of both SCCA-IgM assays and the absence of reactivity not related to immune complexes support the analytical specificity of SCCA-IgM measurements. The results validate the assessment of SCCA-IgM for prognostic purposes in patients with cirrhosis.

Clin Chem Lab Med 2010;48:217–23.

Keywords: autoantibodies; cancer biomarker; cell carcinoma antigen-immunoglobulin M; diagnostic assay; hepatocellular carcinoma; immune complexes; immunesurveillance; natural IgM

About the article

Corresponding author: Luca Beneduce, PhD, XEPTAGEN S.p.A., Via delle Industrie 9, 30175 Marghera Venice, Italy Phone: +39 041 5093910, Fax: +39 041 5093884,


Received: 2009-09-22

Accepted: 2009-10-11

Published Online: 2009-12-10

Published in Print: 2010-02-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2010.044. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Nehad A. Mossad, Enas H. Mahmoud, Enas A. Osman, Sherif H. Mahmoud, and Hend I. Shousha
Tumor Biology, 2014, Volume 35, Number 11, Page 11559
[2]
Caterina Pozzan, Romilda Cardin, Marika Piciocchi, Nora Cazzagon, Gemma Maddalo, Veronica Vanin, Anna Giacomin, Patrizia Pontisso, Umberto Cillo, and Fabio Farinati
Journal of Gastroenterology and Hepatology, 2014, Volume 29, Number 8, Page 1637
[3]
Mario Plebani and Alan H. Wu
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 5
[4]
Christian Anderwald, Hendrik J. Ankersmit, Abdenor Badaoui, Luca Beneduce, Vyacheslav U. Buko, Lorenzo A. Calo, Juan J. Carrero, Chun-Yi Chang, Kuo-Chu Chang, Yi-Jen Chen, Miloslaw Cnotliwy, Paola Costelli, Ana B. Crujeiras, Alberto Cuocolo, Paul A. Davis, Onno J. De Boer, Christoph F. Ebenbichler, Clett Erridge, Giorgio Fassina, Stephan B. Felix, María C. García-Gómez, Fernando Guerrero-Romero, Dominik G. Haider, Akos Heinemann, Lars R. Herda, Ellen K. Hoogeveen, Walter H. Hörl, Bernhard Iglseder, Kuo-Chin Huang, Susanne Kaser, Adnan Kastrati, Nadzeya Kuzniatsova, Giovanni Latella, Michael Lichtenauer, Yung-Kuo Lin, Gregory Y. H. Lip, Nong-Hua Lu, Oxana Lukivskaya, Petra Luschnig, Mauro Maniscalco, J. Alfredo Martinez, Sandra Müller-Krebs, Gjin Ndrepepa, Giovanna Nicolaou, Markus Peck-Radosavljevic, Fabio Penna, Xavier Pintó, Thomas Reiberger, Martha Rodriguez-Moran, Annette Schmidt, Vedat Schwenger, Letizia Spinelli, Peter Starkel, Coen D. A. Stehouwer, Peter Stenvinkel, Peter Strasser, Hiroshi Suzuki, Alexander Tschoner, Allard C. Van Der Wal, David L. Vesely, Chiung-Jung Wen, Ireneusz Wiernicki, Giuliana Zanninelli, and Y. Zhu
European Journal of Clinical Investigation, 2010, Volume 40, Number 9, Page 770

Comments (0)

Please log in or register to comment.
Log in